Skip to main content

Table 3 CMV characteristics

From: Immune recovery uveitis in HIV patients with cytomegalovirus retinitis in the era of HAART therapy—a 5-year study from Singapore

Number of eyes, n 53
Location, n (%)
 Zone 1 15 (28.3)
 Zone 2 23 (43.4)
 Zone 3 11 (20.8)
CMVR involvement retinal area, n (%)
 <25 % 40 (75.5)
 25–50 % 9 (17.0)
 >50 % 4 (7.5)
Duration, days; median (IQR)
 From HIV diagnosis to CMVR diagnosis 283.0 (142.0–539.5)
 From CMVR diagnosis to anti-CMVR treatment 0.0 (0.0–0.0)